Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
The Pune division of the Food and Drug Administration (FDA) has decided to serve a show cause notice to the public sector utility Hindustan Antibiotics Limited for violating norms with regards to drugs close to their expiry date. FDA’s joint commissioner ST Patil told DNA on Tuesday that the company …
American and European regulators issued safety alerts on Thursday about Multaq, a drug approved two years ago to treat abnormal heart rhythms. The Food and Drug Administration said a study of the drug in patients with a long-term form of the disease, known as atrial fibrillation, showed twice as many …
The Food and Drug Administration on Wednesday approved Brilinta, a new blood thinner from AstraZeneca that the company hopes can rival Plavix, the No. 2 best-selling drug in the world. The agency will require a boxed warning about how the drug
AstraZeneca is adding a new heart warning to the labels of Seroquel, its blockbuster antipsychotic drug, at the request of the Food and Drug Administration, company and agency officials said on Monday. Warnings for Seroquel will soon recommend that the drug be avoided in combination with 12 drugs linked to …
On Tuesday, a committee that advises the Food and Drug Administration is to consider whether the first of those drugs can overcome safety concerns and reach the market. The outcome of the F.D.A. review is far from certain. The drug, dapagliflozin, might raise the risk of breast and bladder cancer, …
Copy of EOW report on irregularities has been leaked to the media Despite its details being published in the local Press, the Madhya Pradesh Government is refusing to comment on the investigation report submitted by the Economic Offences Wing on alleged illegal drug trials conducted by Government doctors in Indore. …
Govt admits irregularities, but not taking action against doctor BHOPAL The registration of children, who were born in the year 2010, was done in 2007 for the quarter venlan study, sponsored by Korea. The issue was raised in the state assembly on Tuesday by MLA Paras Sakhlecha during question hour. …
p { margin-bottom: 0.08in; } Gilead Sciences has become the first pharmaceutical company to set up a licensing agreement with the recently-established Medicines Patent Pool (MPP), in a move aimed toward increasing access in developing countries to drugs that treat HIV and Hepatitis B. The landmark deal was announced yesterday, …
No major deficiency found during inspection of Ranbaxy, Orchid, Emcure, Nectar & Ind Swift Facilities The US drug regulator has inspected manufacturing plants of at least half a dozen Indian drugmakers in the last few weeks, raising hopes among some of these companies that they will shortly be able to …
Medicines made from the bulk drugs constitute a third of the drug market The government plans to bring medicines made from 289 essential bulk drugs, constituting nearly a third of the country
Nine-year-old Rani is unhappy. She has to stay away from her mother Janki Patel, who is taking part in a clinical trial at a centre 10 kilometres from her house at Bapu Nagar in Ahmedabad. “I do not like these trials. They take my parents away,” says Rani. In their …
To tighten regulations around clinical trials, a bill was drafted in 2002. Framed as per the guidelines of Indian Council of Medical Research (ICMR), it was submitted to the Ministry of Health and Family Welfare in 2007 to be tabled in Parliament. But it has seen no progress ever since. …
What if a participant dies during a clinical trial? ICMR guidelines clearly mention that a participant must be insured for injuries and deaths. They bind ethics committees to review insurance documents before giving approval for the trial. Contract Research Organisations (CROs) and pharmaceutical companies say they ensure that participants are …
Disclosure is now at the heart of the misappropriation debate—and the centrepiece of vexed international efforts to hammer out a treaty to protect the last major resources of developing nations. Talks in the Geneva-based World Intellectual Property Organisation (WIPO) last month on protecting genetic resources, traditional knowledge and traditional cultural …
Five per cent of the clinical trials conducted across the world will be in India by 2012. They are vital for confirming the efficacy of a new drug, but compromise on ethics. While doctors and organisations conducting trials make big bucks, the rights and safety of the subjects are often …
Global Biggies Slash Research Budget Mumbai: Even as global pharma biggies slashed their research and development (R&D;) spends for the first time ever in 2010, domestic companies have stepped on the gas. Over the last few years, domestic companies have been increasing their research expenditure, and now invest around 6% …
A group of new drugs is promising to prolong the lives and relieve the symptoms of men with advanced prostate cancer, but could also add billions of dollars to the nation
The Narcotics Control Bureau (NCB) today organized a rally at India Gate to mark the International Day against Drug Abuse and Illicit Trafficking. The Delhi social welfare minister Kiran Walia flagged off the rally participated by hundreds of activists. The NCB also put up a museum to educate people on …
